Patents by Inventor Jason Woertink

Jason Woertink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160228448
    Abstract: Ceftolozane Sulfate is a cephalosporin antibacterial agent. Novel, stable, solid forms of the pharmaceutically acceptable sulfate salt of ceftolozane have been isolated via lyophilization. Characterization and identification of these solid forms by XRPD and Raman IR, as well as methods for their preparation and use in pharmaceutical compositions, are described.
    Type: Application
    Filed: September 25, 2014
    Publication date: August 11, 2016
    Inventors: You Seok Hwang, Nicole Miller Damour, Lisa Duong, Valdas Jurkauskas, Kristos Adrian Moshos, Sanjay Mudur, Asli Ovat, Joseph Terracciano, Jason Woertink
  • Publication number: 20150094293
    Abstract: Novel solid forms of ceftolozane are described, as well as methods for the preparation and use of these solid forms.
    Type: Application
    Filed: May 28, 2014
    Publication date: April 2, 2015
    Applicant: CALIXA THERAPEUTICS, INC.
    Inventors: Valdas Jurkauskas, Nicole Miller Damour, Lisa Duong, You Seok Hwang, Kristos Adrian Moshos, Sanjay Mudur, Asli Ovat, Joseph Terracciano, Jason Woertink
  • Patent number: 8906898
    Abstract: Novel solid forms of ceftolozane are described, as well as methods for the preparation and use of these solid forms.
    Type: Grant
    Filed: May 28, 2014
    Date of Patent: December 9, 2014
    Assignee: Calixa Therapeutics, Inc.
    Inventors: You Seok Hwang, Nicole Miller Damour, Lisa Duong, Valdas Jurkauskas, Kristos Adrian Moshos, Sanjay Mudur, Asli Ovat, Joseph Terracciano, Jason Woertink
  • Publication number: 20080108841
    Abstract: Chelating ligand precursors for the preparation of olefin metathesis catalysts are disclosed. The resulting catalysts are air stable monomeric species capable of promoting various metathesis reactions efficiently, which can be recovered from the reaction mixture and reused. Internal olefin compounds, specifically beta-substituted styrenes, are used as ligand precursors. Compared to terminal olefin compounds such as unsubstituted styrenes, the beta-substituted styrenes are easier and less costly to prepare, and more stable since they are less prone to spontaneous polymerization. Methods of preparing chelating-carbene metathesis catalysts without the use of CuCl are disclosed. This eliminates the need for CuCl by replacing it with organic acids, mineral acids, mild oxidants or even water, resulting in high yields of Hoveyda-type metathesis catalysts.
    Type: Application
    Filed: September 11, 2007
    Publication date: May 8, 2008
    Applicant: MATERIA, INC.
    Inventors: Richard Pederson, Jason Woertink, Christopher Haar, David Gindelberger, Yann Schrodi
  • Publication number: 20060122412
    Abstract: Chelating ligand precursors for the preparation of olefin metathesis catalysts are disclosed. The resulting catalysts are air stable monomeric species capable of promoting various metathesis reactions efficiently, which can be recovered from the reaction mixture and reused. Internal olefin compounds, specifically beta-substituted styrenes, are used as ligand precursors. Compared to terminal olefin compounds such as unsubstituted styrenes, the beta-substituted styrenes are easier and less costly to prepare, and more stable since they are less prone to spontaneous polymerization. Methods of preparing chelating-carbene metathesis catalysts without the use of CuCl are disclosed. This eliminates the need for CuCl by replacing it with organic acids, mineral acids, mild oxidants or even water, resulting in high yields of Hoveyda-type metathesis catalysts.
    Type: Application
    Filed: January 31, 2006
    Publication date: June 8, 2006
    Applicant: Materia, Inc.
    Inventors: Richard Pederson, Jason Woertink, Christopher Haar, David Gindelberger, Yann Schrodi